Related Experiment Video
Updated: Aug 11, 2026
07:48
Intravenous Endotoxin Challenge in Healthy Humans: An Experimental Platform to Investigate and Modulate Systemic Inflammation
Published on: May 16, 2016
Causality assessment of adverse effects: when is re-challenge ethically acceptable?
1Centre for Evidence-Based Pharmacotherapy, Aston University, Birmingham, England. a.liwanpo@aston.ac.uk
Drug Safety
|October 23, 2001
Summary
Assessing if a drug causes rare adverse effects through drug re-challenge poses ethical dilemmas. A rigorous framework, similar to clinical trials, is proposed to ensure patient safety and scientific validity.
Area of Science:
- Pharmacovigilance and Drug Safety
- Medical Ethics
- Clinical Trial Methodology
Background:
- Evaluating rare, idiosyncratic adverse drug reactions is challenging.
- Drug de-challenge and re-challenge are methods for causality assessment.
- Serious risks and ethical considerations arise, especially with potentially severe adverse effects.
Purpose of the Study:
- To discuss the ethical issues surrounding drug re-challenge for adverse effect assessment.
- To propose a framework for evaluating the appropriateness of drug re-challenge.
- To highlight the need for rigorous standards in drug re-challenge studies.
Main Methods:
- Review of ethical considerations in drug de-challenge and re-challenge.
- Analysis of case examples (fexofenadine, penicillin, abacavir) illustrating risks.
- Development of a proposed framework for assessing drug re-challenge appropriateness.
Main Results:
- Drug re-challenge, particularly for serious adverse effects, requires careful ethical evaluation.
- Respect for patients and consideration of scientific/social value are crucial.
- Proposed framework emphasizes risk-benefit assessment, scientific preparation, and detailed protocols.
Conclusions:
- Drug re-challenge necessitates the same rigor and documentation standards as clinical trials.
- Ethics committee scrutiny is essential due to potential conflicts of interest.
- Investigators must conduct thorough risk-benefit assessments, ensure scientific preparation, and maintain meticulous records.
Keywords:
Biomedical and Behavioral Research
Related Concept Videos
01:19Pharmacovigilance
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:00Drug Toxicity: Overview
Drug toxicity quantifies the harm a compound causes to an organism, varying by dose and potentially impacting whole systems or specific organs like the liver. Toxic reactions may arise from venomous insect or spider bites, with effects ranging from mild symptoms to severe outcomes such as brain damage or death. Common forms of acute poisoning include ethanol intoxication and overdose of pain or fever medications, with substances like GHB and heroin being particularly lethal at doses close to...
01:24Drug Toxicity: Risk factors
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
01:23Toxicity Testing in Animals
Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...
01:28Criteria for Causality: Bradford Hill Criteria - II
The Bradford Hill criteria serve as guidelines for establishing causative links in epidemiological research. Beyond Strength, Consistency, Specificity, and Temporality, key criteria also include Biological Gradient, Plausibility, Coherence, Experiment, and Analogy. These principles assist scientists in assessing the likelihood of causation in complex biological contexts. Below is a summary of these concepts: